OPEN END TURBO BULL - BB BIOTECH N Share Price

Certificat

DE000CW9FSU9

Market Closed - Börse Stuttgart 08:14:47 03/05/2024 BST
0.76 EUR +5.56% Intraday chart for OPEN END TURBO BULL - BB BIOTECH N
Current month+10.14%
1 month-7.32%
Date Price Change Volume
03/05/24 0.76 +5.56% 0
02/05/24 0.72 +4.35% 0
30/04/24 0.69 +6.15% 0
29/04/24 0.65 0.00% 0
26/04/24 0.65 -4.41% 0

Delayed Quote Börse Stuttgart

Last update May 03, 2024 at 08:14 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BB BIOTECH AG
IssuerLogo Issuer Citi Citi
WKN CW9FSU
ISINDE000CW9FSU9
Date issued 15/02/2016
Strike 27.88 CHF
Maturity Unlimited
Parity 20 : 1
Emission price 0.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.87
Lowest since issue 0.17

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Sector
-
More about the company

Ratings for BB Biotech AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: BB Biotech AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.2 CHF
Average target price
47.7 CHF
Spread / Average Target
+13.03%
Consensus